Log In
BCIQ
Print this Print this
 

EN3342

  Manage Alerts
Collapse Summary General Information
Company Braeburn Pharmaceuticals Inc.
DescriptionSix-month polyurethane implant to deliver risperidone
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase III
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/01/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today